Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Denmark Leads New EU Task Force Exploring Use Of Big Data In Medicines Assessment

Executive Summary

EU drug regulators have created a new task force to establish a roadmap and recommendations on how to use big data in the assessment of medicines.

Advertisement

Related Content

“We Regulators Need To Get Our Heads Round Big Data”: EU Task Force Chair
Interview: EU Big Data Task Force Is ‘Not Just Another Discussion Forum’, Says Chair Thomas Senderovitz
Can Big Data Match Up To The Big Promise?
EMA And National Agency Heads Join Forces On Medicines Availability and Big Data

Topics

Advertisement
UsernamePublicRestriction

Register

PS120291

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel